Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site.

ASX 200 set to fall – WSA, VRT & RAP shares in focus

It was another volatile day for the S&P/ASX 200 (ASX: XJO), with the market trading significantly higher before reversing gains to finish up just 0.1%.

The ASX 200 and individual sectors continue to diverge on a daily basis as the pressure of the 10-year Australian government bond yield impacts valuations very differently.

The financial and banking sector benefits from higher rates via the ability to extract a larger margin on their loans, with Commonwealth Bank of Australia (ASX: CBA) and National Australia Bank Ltd (ASX: NAB) up 1.4% and 1.5%, contributing to a 0.8% return for the sector.

Staples also outperformed as investors once again turn to the likes of Woolworths Group Ltd (ASX: WOW) to protect capital.

The ASX technology and discretionary sectors are the first to sell off whenever yields spike, with both down 0.8% on Monday.

ASX lithium miners pressured, GrainCorp jumps

Mining outperformed despite Australia’s top lithium miners selling off on commentary from one of the leading battery mineral miners. Pilbara Minerals Ltd (ASX: PLS), Novonix Ltd (ASX: NVX) and Mineral Resources Limited (ASX: MIN) were all down more than 3%.

GrainCorp Ltd (ASX: GNC) remains the highlight, up another 7%, as brokers upgrade earnings and dividend expectations on the back of the Russian disruption.

Virtus deal upgraded, Western Areas bid increased

There was no lack of corporate activity on Monday, with IVF and fertility business Virtus Health Ltd (ASX: VRT) deciding to back an improved $8.15 per share takeover offer from CapVest, whilst private equity group BGH remains in the wings.

Shares in Western Areas Ltd (ASX: WSA) jumped another 5.5% after bidder IGO Ltd (ASX: IGO) was forced to increase its takeover offer by 15% to $3.87 per share. The price now trades in line with what is perceived to be fair value.

Pfizer bids for ResApp, Adore Beauty tumbles to new low

Shares in microcap biotech company ResApp Health Ltd (ASX: RAP), which claims to be able to detect COVID-19 through recordings of a cough, jumped 22.2% after Pfizer (NYSE: PFE) announced a $100 million bid for the company, a 27% premium to the last traded price.

On the other side, Adore Beauty Group Ltd (ASX: ABY) shares fell to an all-time low on Monday as the e-commerce led beauty products business fell 8.7%. This takes the loss from the October 2020 $6.75 float price to around 73%.

Meanwhile, BlueScope Steel Limited (ASX: BSL) is utilising strong prices to bulk up, agreeing to a US$500 million deal to buy metal painter Coil Coatings in the US.

ASX 200 today

Looking ahead, the ASX 200 is expected to open lower this morning, following a negative lead from US stock markets overnight. All three benchmarks finished in the red, with the Nasdaq the biggest detractor, falling 2.2%. To find out more, check out my US stock market report.

The Golden Rules of Investing

We might be experts in retirement, but with combined financial advice experience of 35+ years, we’ve nearly seen it all. 

In mid-2023, our senior team at Wattle Partners Financial Planning put the finishing touches on a brand-new report “The Golden Rules of Investing“.

In this free report, we outline the key principles that determine all of the portfolio construction and investment decisions of Wattle Partners. Collated over decades, this paper should be seen as a work-in-progress, constantly under review in light of the ever-evolving nature of markets. 

You’ll find the free report on my Author page. Simply click the button below to view the Golden Rules.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.


At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Powered by

Wattle Partners is a financial advice firm, servicing clients around Australia, specialising in retirement planning (pre and post retirement). 

Skip to content